KADENSA CAPITAL Ltd Invests $24.01 Million in Astera Labs, Inc. $ALAB

KADENSA CAPITAL Ltd acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the third quarter, Holdings Channel reports. The institutional investor acquired 122,609 shares of the company’s stock, valued at approximately $24,007,000. Astera Labs accounts for about 2.5% of KADENSA CAPITAL Ltd’s portfolio, making the stock its 11th biggest position.

Other institutional investors have also made changes to their positions in the company. Clearstead Advisors LLC boosted its holdings in Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after purchasing an additional 76 shares during the last quarter. Great Valley Advisor Group Inc. increased its stake in Astera Labs by 2.2% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after buying an additional 90 shares during the last quarter. Rye Brook Capital LLC lifted its position in Astera Labs by 1.1% during the 3rd quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock worth $1,801,000 after buying an additional 100 shares in the last quarter. Assetmark Inc. boosted its stake in shares of Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after buying an additional 101 shares during the last quarter. Finally, SlateStone Wealth LLC boosted its stake in shares of Astera Labs by 1.3% during the 3rd quarter. SlateStone Wealth LLC now owns 12,744 shares of the company’s stock worth $2,495,000 after buying an additional 160 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on ALAB shares. BNP Paribas Exane began coverage on Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating on the stock. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Morgan Stanley reiterated an “overweight” rating and set a $210.00 price objective on shares of Astera Labs in a research note on Wednesday, December 3rd. Finally, Loop Capital began coverage on Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective for the company. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $202.22.

Insider Activity at Astera Labs

In related news, CEO Jitendra Mohan sold 94,971 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the sale, the chief executive officer owned 1,452,739 shares in the company, valued at approximately $179,863,615.59. This represents a 6.14% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jack R. Lazar sold 7,500 shares of the firm’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $119.80, for a total value of $898,500.00. Following the sale, the director directly owned 87,351 shares of the company’s stock, valued at $10,464,649.80. This represents a 7.91% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 224,292 shares of company stock worth $27,676,069 in the last three months. 12.50% of the stock is owned by company insiders.

Astera Labs Stock Performance

Shares of ALAB stock opened at $120.31 on Monday. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90. The stock has a market cap of $20.48 billion, a price-to-earnings ratio of 98.61, a PEG ratio of 2.37 and a beta of 1.75. The firm’s 50-day moving average is $147.89 and its 200-day moving average is $168.03.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s quarterly revenue was up 91.8% on a year-over-year basis. During the same quarter last year, the company posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.